home / stock / bfri / bfri short
Short Information | Biofrontera Inc. (NASDAQ:BFRI)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 90,006 |
Total Actual Volume | 543,168 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 1 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 4,500 |
Average Short Percentage | 16.32% |
Is there a BFRI Short Squeeze or Breakout about to happen?
See the BFRI Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $0.869 | $0.84 | $0.891899 | $0.84 | 28,484 | 14,471 | 50.8% |
07-01-2024 | $0.898 | $0.892 | $0.9 | $0.8683 | 20,448 | 137 | 0.67% |
06-28-2024 | $0.93 | $0.898 | $0.93 | $0.89 | 14,571 | 3,453 | 23.7% |
06-27-2024 | $0.94 | $0.900001 | $0.94 | $0.86 | 36,445 | 2,466 | 6.77% |
06-26-2024 | $0.98 | $0.91 | $0.98 | $0.9 | 29,923 | 1,565 | 5.23% |
06-25-2024 | $0.9 | $0.95 | $0.95 | $0.9 | 28,240 | 6,874 | 24.34% |
06-24-2024 | $0.94 | $0.9006 | $0.9799 | $0.9 | 46,807 | 4,274 | 9.13% |
06-21-2024 | $1.0199 | $0.9515 | $1.0399 | $0.9515 | 45,659 | 2,443 | 5.35% |
06-20-2024 | $1.03 | $1.03 | $1.03 | $0.96 | 10,758 | 125 | 1.16% |
06-18-2024 | $1.03 | $1 | $1.05 | $0.998 | 13,189 | 3,184 | 24.14% |
06-17-2024 | $1.09 | $1.03 | $1.1 | $1.0201 | 15,437 | 180 | 1.17% |
06-14-2024 | $0.982 | $1.085 | $1.1 | $0.96 | 32,709 | 10,186 | 31.14% |
06-13-2024 | $1.015 | $0.99 | $1.02 | $0.94 | 35,539 | 9,479 | 26.67% |
06-12-2024 | $1.01 | $1.03 | $1.05 | $0.9402 | 15,999 | 3,783 | 23.65% |
06-11-2024 | $0.92 | $0.9401 | $1.01 | $0.87 | 23,229 | 460 | 1.98% |
06-10-2024 | $0.99 | $0.94 | $1.0099 | $0.9 | 42,098 | 3,983 | 9.46% |
06-07-2024 | $1.04 | $0.99 | $1.04 | $0.9709 | 21,741 | 404 | 1.86% |
06-06-2024 | $1 | $1.02 | $1.02 | $0.97 | 36,776 | 12,002 | 32.64% |
06-05-2024 | $1.03 | $1.005 | $1.07 | $1.0001 | 23,446 | 5,965 | 25.44% |
06-04-2024 | $1.028 | $1.04 | $1.06 | $1.0009 | 21,670 | 4,572 | 21.1% |
News, Short Squeeze, Breakout and More Instantly...
The RhodoLED XL is approved by the FDA in combination with Ameluz ® (aminolevulinic acid hydrochloride) topical gel, 10% for photodynamic therapy (PDT) of actinic keratoses of mild-to-moderate severity on the face and scalp Biofrontera launched the commercial distribution of the Rhod...
Conference call begins at 10:00 a.m. Eastern time on Thursday, May 16, 2024 WOBURN, MA / ACCESSWIRE / May 15, 2024 / Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today reported financial results f...
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...